Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Associates IV Llc Proquest currently holds 9,738 shares of EAGLE PHARMACEUTICALS, INC. (EGRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Associates IV Llc Proquest has been a net seller of EGRX stock. They have purchased $4.7M and sold $49.2M worth of shares.
Associates IV Llc Proquest's most recent insider trade was on Apr 25, 2017, when they sold 51,219 shares at $88.34 per share.
Associates IV Llc Proquest serves as Executive at EAGLE PHARMACEUTICALS, INC. (EGRX). They have executed 46 insider transactions totaling $53.9M over their tenure at the company.
Associates IV Llc Proquest holds the position of Executive at EAGLE PHARMACEUTICALS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Associates IV Llc Proquest has shown a selling trading pattern, with $4.7M in total purchases and $49.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Associates IV Llc Proquest was on Nov 2, 2016, when they sold $10.2M worth of EGRX shares. This transaction involved 146,371 shares at $70.00 per share.
Associates IV Llc Proquest currently owns 9,738 shares of EAGLE PHARMACEUTICALS, INC. (EGRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Associates IV Llc Proquest's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Associates IV Llc Proquest has 46 Form 4 filings on record as an insider at EAGLE PHARMACEUTICALS, INC..
Set alerts for Associates IV Llc Proquest and 40,000+ other insiders.